(Q33754346)

29 July 2017

1 reference

title

The role of beta-lactam/beta-lactamase inhibitors in the management of mixed infections (English)

1 reference

29 July 2017

Akalin HE

1

1 reference

29 July 2017

publication date

1 August 1999

1 reference

International Journal of Antimicrobial Agents

29 July 2017

published in

1 reference

29 July 2017

volume

12 Suppl 1

1 reference

29 July 2017

page(s)

S15-20; discussion S26-7

1 reference

Secondary bacterial peritonitis: The biologic basis of treatment

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Aerobic and anaerobic bacteria in diabetic foot ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Microbiology, chemotherapy and mortality of brain abscess in Newcastle-upon-Tyne between 1979 and 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Randomized, double-blind study of cefotetan and cefoxitin in post-cesarean section endometritis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Penetration of sulbactam and ampicillin into peritoneal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Concentration of sulbactam and ampicillin in serum and the myometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Abdominal surgical wound infection is lowered with improved perioperative enterococcus and bacteroides therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Pathophysiology and management of postcesarean endomyometritis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Foot infections in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Treatment of intracranial abscesses: experience with sulbactam/ampicillin.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

Ampicillin/sulbactam versus cefotetan for the prevention of infection following cesarean delivery in high-risk patients: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900087-4

7 January 2021

10.1016/S0924-8579(99)00087-4

Identifiers

DOI

1 reference

29 July 2017

1 reference